Muromonab (anti-CD3) 是一种靶向 CD3 抗原的鼠源 IgG2a mAb。Muromonab (anti-CD3) 特异性结合人类和高等灵长类动物的 T 细胞表面 CD3 抗原。Muromonab (anti-CD3) 可阻断 T 细胞受体识别外来抗原的功能,抑制 T 细胞介导的免疫反应,包括细胞介导的淋巴细胞溶解和 T 细胞增殖反应。Muromonab (anti-CD3) 可用于研究急性肾、肝、心脏和联合肾脏-胰腺移植排斥反应,还可用于研究骨髓移植患者的移植物抗宿主病。
Muromonab (anti-CD3) is a mouse monoclonal antibody targeting the CD3 antigen. Muromonab (anti-CD3) specifically binds to the CD3 antigen on the surface of human and higher primate T cells. Muromonab (anti-CD3) blocks the function of T cell receptors to recognize foreign antigens and inhibits T cell-mediated immune responses, including cell-mediated lymphocyte lysis and T cell proliferation responses. Muromonab (anti-CD3) can be used to study acute kidney, liver, heart and combined kidney-pancreas transplant rejection, and can also be used to study graft-versus-host disease in bone marrow transplant patients.